| Human bone marrow–derived mesenchymal stem cells in the treatment of gliomas A Nakamizo, F Marini, T Amano, A Khan, M Studeny, J Gumin, J Chen, ... Cancer research 65 (8), 3307-3318, 2005 | 1381 | 2005 |
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents M Studeny, FC Marini, JL Dembinski, C Zompetta, M Cabreira-Hansen, ... Journal of the National Cancer Institute 96 (21), 1593-1603, 2004 | 1102 | 2004 |
| Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression EL Spaeth, JL Dembinski, AK Sasser, K Watson, A Klopp, B Hall, ... PloS one 4 (4), e4992, 2009 | 978 | 2009 |
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging S Kidd, E Spaeth, JL Dembinski, M Dietrich, K Watson, A Klopp, ... Stem cells 27 (10), 2614-2623, 2009 | 810 | 2009 |
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells E Spaeth, A Klopp, J Dembinski, M Andreeff, F Marini Gene therapy 15 (10), 730-738, 2008 | 723 | 2008 |
| Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment AH Klopp, EL Spaeth, JL Dembinski, WA Woodward, A Munshi, RE Meyn, ... Cancer research 67 (24), 11687-11695, 2007 | 393 | 2007 |
| The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells SB Coffelt, FC Marini, K Watson, KJ Zwezdaryk, JL Dembinski, ... Proceedings of the National Academy of Sciences 106 (10), 3806-3811, 2009 | 367 | 2009 |
| Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma JL Dembinski, S Krauss Clinical & experimental metastasis 26, 611-623, 2009 | 306 | 2009 |
| Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles B Hall, J Dembinski, AK Sasser, M Studeny, M Andreeff, F Marini International journal of hematology 86, 8-16, 2007 | 237 | 2007 |
| Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth J Waaler, O Machon, JP von Kries, SR Wilson, E Lundenes, D Wedlich, ... Cancer research 71 (1), 197-205, 2011 | 183 | 2011 |
| Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer JL Dembinski, SM Wilson, EL Spaeth, M Studeny, C Zompetta, I Samudio, ... Cytotherapy 15 (1), 20-32. e2, 2013 | 86 | 2013 |
| Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells JL Dembinski, EL Spaeth, J Fueyo, C Gomez-Manzano, M Studeny, ... Cancer gene therapy 17 (4), 289-297, 2010 | 79 | 2010 |
| Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity JL Dembinski, O Hungnes, AG Hauge, AC Kristoffersen, B Haneberg, ... Journal of virological methods 207, 232-237, 2014 | 53 | 2014 |
| High sensitivity measurements of active oxysterols with automated filtration/filter backflush-solid phase extraction-liquid chromatography–mass spectrometry H Roberg-Larsen, MF Strand, A Grimsmo, PA Olsen, JL Dembinski, ... Journal of chromatography A 1255, 291-297, 2012 | 47 | 2012 |
| HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women … K Zaman, S Dudman, K Stene-Johansen, F Qadri, M Yunus, S Sandbu, ... BMJ open 10 (1), e033702, 2020 | 46 | 2020 |
| Epitope specific T‐cell responses against influenza A in a healthy population M Savic, JL Dembinski, Y Kim, G Tunheim, RJ Cox, F Oftung, B Peters, ... Immunology 147 (2), 165-177, 2016 | 44 | 2016 |
| Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021 KSM Benschop, J Albert, A Anton, C Andrés, M Aranzamendi, ... Eurosurveillance 26 (45), 2100998, 2021 | 43 | 2021 |
| Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment K Lund, JL Dembinski, N Solberg, A Urbanucci, IG Mills, S Krauss PloS one 10 (4), e0123684, 2015 | 40 | 2015 |
| A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model MF Strand, SR Wilson, JL Dembinski, DD Holsworth, A Khvat, I Okun, ... PLoS One 6 (6), e19904, 2011 | 31 | 2011 |
| Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe KSM Benschop, EK Broberg, E Hodcroft, D Schmitz, J Albert, A Baicus, ... Emerging infectious diseases 27 (6), 1616, 2021 | 26 | 2021 |
